Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Growth 2024-2030

Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Growth 2024-2030

PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.

The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Forecast” looks at past sales and reviews total world PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales in 2023, providing a comprehensive analysis by region and market sector of projected PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales for 2024 through 2030. With PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PET Radioisotope (Radiopharmaceuticals in PET Imaging) industry.

This Insight Report provides a comprehensive analysis of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PET Radioisotope (Radiopharmaceuticals in PET Imaging) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PET Radioisotope (Radiopharmaceuticals in PET Imaging) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PET Radioisotope (Radiopharmaceuticals in PET Imaging).

United States market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key PET Radioisotope (Radiopharmaceuticals in PET Imaging) players cover IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company and Mallinckrodt Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of PET Radioisotope (Radiopharmaceuticals in PET Imaging) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
11C
13N
150
18F
Others

Segmentation by application
Medical Imaging
Scientific Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM

Key Questions Addressed in this Report

What is the 10-year outlook for the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?

What factors are driving PET Radioisotope (Radiopharmaceuticals in PET Imaging) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do PET Radioisotope (Radiopharmaceuticals in PET Imaging) market opportunities vary by end market size?

How does PET Radioisotope (Radiopharmaceuticals in PET Imaging) break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.